Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts ; volume:15 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-12 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (10.10.2017), 1-12, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Huang, Ruixia
- Beteiligte Personen und Organisationen
-
Andersen, Lise Mari K.
Rofstad, Einar K.
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1307-4
- URN
-
urn:nbn:de:1111-2017111510691
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Ruixia
- Andersen, Lise Mari K.
- Rofstad, Einar K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
Evolution of thymopoietic microenvironments
Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
Purinergic signaling microenvironments: An introduction
Biomimetic microenvironments for regenerative endodontics
Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma
Mimicking 3D tumor microenvironments in vitro
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
Evolution of thymopoietic microenvironments
Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
Purinergic signaling microenvironments: An introduction
Biomimetic microenvironments for regenerative endodontics
Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma
Mimicking 3D tumor microenvironments in vitro
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments **
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
Evolution of thymopoietic microenvironments
Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
Purinergic signaling microenvironments: An introduction
Biomimetic microenvironments for regenerative endodontics
Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma